Trials / Unknown
UnknownNCT03659110
Post-Approval Safety Monitoring Program to Assess the Safety Profile of GARDASIL in China Usual Practice
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Beijing Chaoyang District Centre for Disease Control and Prevention · Academic / Other
- Sex
- Female
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This is a post-Approval Safety Monitoring Program to assess the safety profile of GARDASIL in china usual practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | HPV 4 | 1000 subjects will be received the HPV 4 vaccine |
Timeline
- Start date
- 2018-10-01
- Primary completion
- 2021-07-30
- Completion
- 2021-12-30
- First posted
- 2018-09-06
- Last updated
- 2018-09-27
Source: ClinicalTrials.gov record NCT03659110. Inclusion in this directory is not an endorsement.